⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TLSI News
TriSalus Life Sciences, Inc. Common Stock
TriSalus Life Sciences Reports Third Quarter 2025 Results and Reaffirms 2025 Revenue Guidance
businesswire.com
TLSI
TriSalus Life Sciences to Participate in Upcoming Investor Conferences
businesswire.com
TLSI
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Uterine Fibroids on November 12, 2025
businesswire.com
TLSI
TriSalus Life Sciences to Host Third Quarter 2025 Financial Results Conference Call
businesswire.com
TLSI